Published in PLoS One on January 11, 2016
Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle. Sci Rep (2017) 0.85
Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort. J Am Heart Assoc (2016) 0.83
Microbiome, trimethylamine N-oxide, and cardiometabolic disease. Transl Res (2016) 0.80
An overview of renal metabolomics. Kidney Int (2016) 0.77
Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol (2016) 0.76
Trimethylamine N-Oxide: The Good, the Bad and the Unknown. Toxins (Basel) (2016) 0.75
The role of epigenetics in renal ageing. Nat Rev Nephrol (2017) 0.75
The gut-kidney axis. Pediatr Nephrol (2016) 0.75
Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function. United European Gastroenterol J (2016) 0.75
NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting. Clin Biochem (2017) 0.75
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med (2013) 8.21
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int (1999) 4.25
Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab (2013) 3.01
Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int (1998) 2.60
Chronic kidney disease alters intestinal microbial flora. Kidney Int (2012) 2.58
Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res (2014) 2.02
Colonic contribution to uremic solutes. J Am Soc Nephrol (2011) 1.98
Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol (1999) 1.90
Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin Chem (2014) 1.84
Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant (2006) 1.70
The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol (2013) 1.67
Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis (2009) 1.54
A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol (2013) 1.42
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med (2014) 1.35
Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. Am J Gastroenterol (1985) 1.24
Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta (1991) 1.24
Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol (2014) 1.24
Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J Card Fail (2014) 1.24
Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol (2014) 1.16
Chronic kidney disease and premature ageing. Nat Rev Nephrol (2014) 1.16
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol (2015) 1.15
Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.11
Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. Am J Clin Nutr (2014) 1.10
Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients. Nephrology (Carlton) (2008) 0.99
Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Am J Nephrol (2013) 0.97
Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. J Ren Nutr (2015) 0.96
Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study. BMJ Open (2014) 0.89
Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4. Angiology (2013) 0.84
Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine. AIDS (2015) 0.83
A Review of Dietary Intake Studies in Maintenance Dialysis Patients. J Ren Nutr (2015) 0.78